Second-quarter recovery in hearing aid revenue
First written in FY2017-Q2. 8 of 30 entries say "Advanced", first in FY2017. Latest entry: FY2027-H1.
No other company in this theme has enough history to compare yet.
- FY2027-H1Hearing aid revenue increased on the back of subsidy programs and new products.Annual report
「In hearing aids, customer traffic remained firm against the backdrop of municipal subsidies for hearing aid purchases, among other factors, while the Rionet Plus series, which accurately addressed market needs, contributed to sales, resulting in higher revenue than in the previous interim consolidated accounting period.」
Whereas the previous period described restrained personal consumption due to high prices, hearing aid sales exceeded the previous interim period's level, supported by firm customer traffic against the backdrop of municipal purchase subsidies and contributions from Rionet Plus sales. - FY2026-H1AdvancedAnnual report
「Sales increased from the previous interim consolidated accounting period, due in part to firm sales of the new Rionet Plus hearing aid product.」
Despite the impact of restrained personal consumption due to rising prices, firm sales of Rionet Plus hearing aids lifted hearing aid sales above the previous interim period's level. - FY2025The trend shifted from higher revenue driven by strong customer traffic to lower revenue due to weak personal consumption.Annual report
「In hearing aids, the company worked to expand sales, centered on the Rionet 2 series, but revenue declined from the previous consolidated fiscal year, when customer traffic had remained strong, due partly to weaker personal consumption resulting from continuing price increases.」
Although the company expanded sales, centered on new products, the trend shifted from the recovery in social activity that had supported strong customer traffic in the previous fiscal year to lower revenue against the backdrop of weaker personal consumption due to rising prices. - FY2025-H1The trend shifted from higher revenue driven by strong customer traffic as social activity recovered to lower revenue due to weak personal consumption.Annual report
「Revenue declined compared with the previous interim consolidated accounting period, when visitor numbers had remained strong as social activity recovered from the COVID-19 pandemic, due to a decline in personal consumption caused by continuing inflation.」
The trend changed from higher revenue driven by strong customer traffic in the previous interim period to lower hearing aid revenue against the backdrop of rising prices and weaker personal consumption. - FY2024AdvancedAnnual report
「In hearing aids, sales of high-value-added products, centered on the new Rionet 2 custom hearing aid, contributed to revenue growth, while customer traffic also remained strong as social activity recovered.」
In addition to recovering customer traffic, high-value-added products, centered on the Rionet 2 custom hearing aid, were identified as a driver of higher hearing aid revenue. Hearing aid sales were ¥10,145 million. - FY2024-Q3ReframedAnnual report
「In hearing aids, customer traffic remained strong as social activity recovered, while sales of high-value-added products, centered on new products, also contributed to higher revenue.」
Whereas replacement demand from existing customers was identified in the previous quarter, this quarter's factors driving higher revenue were described as increased customer traffic from the recovery in social activity and sales of high-value-added products, centered on new products. - FY2024-Q2Replacement demand from existing customers identified as a new driver of higher revenue.Annual report
「In hearing aids, customer traffic was on an upward trend as social activity recovered, while rising replacement demand from existing customers also resulted in higher revenue.」
In addition to increased customer traffic as social activity recovered, rising replacement demand from existing customers was identified for the first time as a driver of higher hearing aid revenue. - FY2024-Q1AdvancedAnnual report
「As social activity gradually returned to normal, customer traffic, including referrals from otolaryngology clinics, was on an upward trend, resulting in higher revenue.」
Customer traffic at hearing aid retailers was on an upward trend, and hearing aid revenue increased year on year against the backdrop of social activity returning to normal. - FY2023RestatedAnnual report
「As daily life recovered with the spread of infections subsiding, customer traffic was on a gradual recovery trend overall, resulting in higher revenue.」
Customer traffic at hearing aid retailers entered a gradual recovery trend, resulting in higher hearing aid revenue. - FY2023-Q3Customer traffic entered a gradual recovery trend.Annual report
「In hearing aids, although customer traffic at hearing aid retailers remained sluggish during the period when COVID-19 was spreading, the easing of activity restrictions put customer traffic on a gradual recovery trend overall, resulting in higher revenue.」
Although customer traffic stagnated as infections resurged, the easing of activity restrictions put it on a gradual recovery trend overall, resulting in higher hearing aid revenue. - FY2023-Q2Customer traffic declined again, but sales exceeded the year-earlier level.Annual report
「In hearing aids, customer traffic was on a recovery trend from April through June as activity restrictions related to COVID-19 were eased, but declined again from July onward due to the resurgence of infections. Nevertheless, sales for the first half as a whole exceeded those in the same quarter of the previous year, when customer traffic was constrained by the declaration of a state of emergency and the implementation of priority preventive measures.」
Customer traffic recovered from April through June but declined again from July onward as infections resurged. Even so, hearing aid sales for the first half exceeded the year-earlier level. - FY2023-Q1AdvancedAnnual report
「In hearing aids, customer traffic recovered as restrictions on activity related to COVID-19 were eased, and sales exceeded those in the same quarter of the previous year, when customer traffic had been sluggish due to the spread of infections.」
Against the backdrop of recovering customer traffic following the easing of activity restrictions, hearing aid sales exceeded the year-earlier level. - FY2022-Q3Hearing aid sales began to recover as customer traffic returned.Annual report
「As customer traffic returned from October onward, both visitor numbers and sales were on a recovery trend, so the decline was not as severe as in the same quarter of the previous year.」
Although customer traffic and sales remained sluggish through the second quarter, both began to recover from October onward as customer traffic returned. - FY2022-Q2RestatedAnnual report
「Visitor numbers at hearing-aid retailers were sluggish due to requests to refrain from going out to prevent the spread of COVID-19, but the decline did not reach the level seen in the same quarter of the previous year.」
The company continued to explain that although customer traffic at hearing aid retailers remained sluggish, sales did not decline as much as in the same period of the previous year. - FY2022-Q1Sales exceeded the previous year even during the fourth waveAnnual report
「In hearing aids, customer traffic at hearing aid retailers remained sluggish from around April due to the arrival of the fourth wave of COVID-19, but the decline was not as severe as in the same quarter of the previous year, when the first state of emergency was declared.」
The company explained that although customer traffic remained sluggish, it did not decline as much as in the same period of the previous year, and hearing aid sales exceeded the year-earlier level. - FY2021Full-year revenue fell below the previous year as infections resurged after the recoveryAnnual report
「Thereafter, the resurgence of infections from around November caused sales conditions to deteriorate again from January to February, and although a recovery was seen in March, full-year revenue fell short of the previous consolidated fiscal year.」
Hearing aid sales recovered from June onward and exceeded the previous year in October, but deteriorated again in January and February as infections resurged, resulting in full-year revenue of ¥9,062 million, down 8.0% year on year. - FY2021-Q3AdvancedAnnual report
「From June onward, both visitor numbers and sales have been recovering, and in the second half they remained above the previous year's levels.」
The company explained that, after the sharp decline in hearing aid sales from April to May and the recovery trend from June onward, sales in the second half reached a level above the previous year. - FY2021-Q2Trend toward recovery from the decline caused by restrictions on going outAnnual report
「Although sales fell sharply from April to May as the number of store visitors declined, both visitor numbers and sales showed signs of recovery from June onward and remained near the level of the same month of the previous year.」
Hearing aid sales fell sharply from April to May, but both store visits and sales showed a recovery trend from June onward. - FY2021-Q1Sales shifted from exceeding the previous year to weakeningAnnual report
「Hearing aid sales were sluggish owing in part to the decline in visits to hearing aid retailers, including referrals from otolaryngology clinics, as people refrained from going out,」
Hearing aid revenue, which had exceeded the same period of the previous year through the previous fiscal year on the strength of high- and mid-priced products, became sluggish as visits declined because people refrained from going out. - FY2020-Q3RestatedAnnual report
「In hearing aids, sales of the mid-priced product launched in February 2019 remained strong, among other factors, causing revenue to exceed the same quarter of the previous year.」
Hearing aid revenue continued to exceed the same period of the previous year, driven by strong sales of the mid-priced product launched in February 2019. - FY2020-Q2RestatedAnnual report
「In hearing aids, sales of the mid-priced product launched in February 2019 remained strong, causing revenue to exceed the same quarter of the previous year.」
The year-on-year outperformance of hearing aid revenue driven by mid-priced products, noted in the previous quarter, continued. - FY2020-Q1ReframedAnnual report
「In hearing aids, sales of the mid-priced product launched in February 2019 remained strong, causing revenue to exceed the same quarter of the previous year.」
The explanation shifted from strong sales centered on existing high-priced products to one in which the mid-priced product launched in February 2019 supported hearing aid revenue. - FY2019-Q3RestatedAnnual report
「In hearing aids, sales of the high-priced Rionet Series remained strong, causing revenue to exceed the same quarter of the previous year.」
Hearing aid revenue continued to exceed the same period of the previous year, driven by strong sales of high-priced products. - FY2019-Q2RestatedAnnual report
「In hearing aids, sales of the high-priced Rionet Series remained strong, causing revenue to exceed the same quarter of the previous year.」
Hearing aid revenue continued to exceed the same period of the previous year, driven by strong sales of high-priced products, including the new products confirmed in the previous quarter. - FY2019-Q1RestatedAnnual report
「In hearing aids, sales of the product launched in August 2017 remained strong, causing revenue to exceed the same quarter of the previous year.」
The year-on-year outperformance of hearing aid revenue from new products confirmed in the third quarter of the previous fiscal year continued into the current first quarter. - FY2018-Q3AdvancedAnnual report
「Revenue exceeded the same quarter of the previous year, owing in part to strong sales of the new product launched in late August 2017, which covered the decline in the cumulative second-quarter consolidated period.」
After the strong start of the high-priced new product in the previous quarter, the new product covered the decline during the cumulative period and hearing aid revenue exceeded the same period of the previous year. - FY2018-Q2Strong sales of new high-priced products, but sluggish sales overall for hearing aidsAnnual report
「In hearing aids, the high-priced product launched in late August this year got off to a strong start, but revenue declined owing in part to sluggish sales overall.」
While the new high-priced product performed well, sales were sluggish across hearing aids overall, resulting in lower revenue. - FY2018-Q1Hearing aids saw lower revenue as strong new products failed to offset weakness in low-priced productsAnnual report
「In hearing aids, products launched last year sold well, but revenue declined owing in part to sluggish sales of low-priced products.」
After hearing aid revenue had exceeded the previous fiscal year in the previous full fiscal year, revenue declined in the current first quarter as strong sales of new products were offset by weak sales of low-priced products. - FY2017AdvancedAnnual report
「Hearing aid revenue exceeded the previous consolidated fiscal year」
After sluggish growth in the first quarter, hearing aid revenue progressed to a level above the previous fiscal year for the full year. - FY2017-Q2First statedAnnual report
「In addition to the recovery in hearing aid revenue after the start of the second-quarter consolidated period」
The company reported that hearing aid revenue recovered in the second quarter after sluggish growth in the first quarter.